Registration for slightly modified drugs on cross road.

Even during the drug registration review for any original new drug, the industry claimed that the health registration for a slightly modified new drug, for instance, developing a new salt derivative from the original compound be possible, interpreting Article 30 (new drugs and items to review etc.) of the working rule of the Pharmaceutical Affairs Act that the registration shall not restrict to...